FAM111B
Basic information
Region (hg38): 11:59107185-59127412
Links
Phenotypes
GenCC
Source:
- hereditary sclerosing poikiloderma with tendon and pulmonary involvement (Supportive), mode of inheritance: AD
- hereditary sclerosing poikiloderma with tendon and pulmonary involvement (Moderate), mode of inheritance: AD
- hereditary sclerosing poikiloderma with tendon and pulmonary involvement (Moderate), mode of inheritance: AD
- hereditary sclerosing poikiloderma with tendon and pulmonary involvement (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Dermatologic; Musculoskeletal; Pulmonary | 24268661 |
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn_genetic_diseases (100 variants)
- Hereditary_sclerosing_poikiloderma_with_tendon_and_pulmonary_involvement (19 variants)
- not_provided (14 variants)
- FAM111B-related_disorder (8 variants)
- not_specified (4 variants)
- Pulmonary_fibrosis (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FAM111B gene is commonly pathogenic or not. These statistics are base on transcript: NM_000198947.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 103 | 13 | 124 | |||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 6 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 3 | 4 | 108 | 17 | 4 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FAM111B | protein_coding | protein_coding | ENST00000343597 | 2 | 20226 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0985 | 0.596 | 114646 | 0 | 19 | 114665 | 0.0000829 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.234 | 402 | 389 | 1.03 | 0.0000197 | 4926 |
Missense in Polyphen | 68 | 68.609 | 0.99113 | 865 | ||
Synonymous | 0.596 | 128 | 137 | 0.935 | 0.00000731 | 1296 |
Loss of Function | 0.127 | 1 | 1.15 | 0.872 | 4.81e-8 | 16 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00108 | 0.00108 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00108 | 0.00108 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
Intolerance Scores
- loftool
- 0.544
- rvis_EVS
- -0.73
- rvis_percentile_EVS
- 14.14
Haploinsufficiency Scores
- pHI
- 0.0654
- hipred
- N
- hipred_score
- 0.112
- ghis
- 0.589
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0259
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- Cellular component
- Molecular function
- protein binding